Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.26
+0.21 (4.16%)
Jul 13, 2026, 4:00 PM EDT - Market closed
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $490.82 million as of July 13, 2026. Its market cap has increased by 2.75% in one year.
Market Cap
490.82M
Enterprise Value
609.67M
1-Year Change
2.75%
Ranking
Category
Stock Price
$5.26
Market Cap Chart
Since the IPO on May 6, 2021, Valneva SE's market cap has decreased from $1.29B to $490.82M, a decrease of -62.03%. That is a compound annual growth rate of -17.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 490.82M | -34.92% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 126.51% |
| May 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 492.64M |
| Verastem | 485.94M |
| Zura Bio | 485.44M |
| Cabaletta Bio | 485.09M |
| Prothena Corporation | 483.74M |
| Prelude Therapeutics | 476.55M |
| Evommune | 475.80M |
| Ovid Therapeutics | 470.33M |